(Q45298929)

11 December 2017

title

Reduced basal ganglia blood flow and volume in pre-symptomatic, gene-tested persons at-risk for Huntington's disease (English)

1 reference

11 December 2017

0 references

6

1 reference

11 December 2017

Harris GJ

1

1 reference

11 December 2017

Codori AM

2

1 reference

11 December 2017

Lewis RF

3

1 reference

11 December 2017

Schmidt E

4

1 reference

11 December 2017

Bedi A

5

1 reference

11 December 2017

language of work or name

English

0 references

publication date

1 September 1999

1 reference

11 December 2017

1 reference

11 December 2017

volume

122 ( Pt 9)

1 reference

11 December 2017

page(s)

1667-1678

1 reference

Parallel Organization of Functionally Segregated Circuits Linking Basal Ganglia and Cortex

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.9.1667

Reduced basal ganglia volume associated with the gene for Huntington's disease in asymptomatic at-risk persons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.9.1667

Basal ganglia volume and proximity to onset in presymptomatic Huntington disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.9.1667

Clinical-pathologic correlation in Huntington's disease: a neuropsychological and computed tomography study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.9.1667

Bicaudate index in computerized tomography of Huntington disease and cerebral atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.9.1667

Psychiatric, genetic, and positron emission tomographic evaluation of persons at risk for Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.9.1667

Positron emission tomographic scan investigations of Huntington's disease: cerebral metabolic correlates of cognitive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.9.1667

Atrophy of corpus striatum in normal male at risk of Huntington's chorea

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.9.1667

Cerebral blood flow velocity decreases during cognitive stimulation in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.9.1667

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.9.1667

Reduced striatal glucose consumption and prolonged reaction time are early features in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.9.1667

A comparison of neurological, metabolic, structural, and genetic evaluations in persons at risk for Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.9.1667

Serial changes of cerebral glucose metabolism and caudate size in persons at risk for Huntington's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.9.1667

MRI-guided region of interest placement on emission computed tomograms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.9.1667

Putamen volume reduction on magnetic resonance imaging exceeds caudate changes in mild Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.9.1667

Single photon emission computed tomographic blood flow and magnetic resonance volume imaging of basal ganglia in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.9.1667

Reduced regional cerebral blood flow in Huntington's disease studied by SPECT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.9.1667

Positron emission tomography in the early diagnosis of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.9.1667

The combined use of positron emission tomography and DNA polymorphisms for preclinical detection of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.9.1667

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.9.1667

Cerebral structure on MRI, part II: Specific changes in Alzheimer's and Huntington's diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.9.1667

Cerebral metabolism and atrophy in huntington's disease determined by18FDG and computed tomographic scan

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.9.1667

Cerebral glucose consumption measured by PET in patients with and without psychiatric symptoms of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.9.1667

Cortical and subcortical glucose consumption measured by PET in patients with Huntington's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.9.1667

Striatal glucose consumption in chorea-free subjects at risk of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.9.1667

Comparison of somatosensory evoked potentials with striatal glucose consumption measured by positron emission tomography in the early diagnosis of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.9.1667

Cortical glucose metabolism in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.9.1667

Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.9.1667

Diagnostic value of CT in patients with Huntington's chorea and their offspring

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.9.1667

Trial of d-alpha-tocopherol in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.9.1667

Neuronal distribution in the putamen in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.9.1667

Computed Tomographic, Neurologic, and Neuropsychological Correlates of Huntington'S Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.9.1667

Neuropsychological and neuroradiological correlates in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.9.1667

Brain atrophy in Huntington's disease. A CT-scan study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.9.1667

PET scan investigations of Huntington's disease: cerebral metabolic correlates of neurological features and functional decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.9.1667

Normal caudate glucose metabolism in persons at risk for Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.9.1667

Laboratory Guidelines for Huntington Disease Genetic Testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.9.1667

21 January 2018

Identifiers

DOI

10.1093/BRAIN/122.9.1667

1 reference

11 December 2017

1 reference